Home › Opioid Overdose › Washington › Seattle
Opioid Overdose clinical trials in Seattle, WA
4 studies for Opioid Overdose are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Brenipatide in Participants With Opioid Use Disorder
RecruitingPhase 2
- University of Washington - Harborview Medical Center, Seattle
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
RecruitingPhase 4
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RecruitingHealthy volunteers welcome
- University of Washington, Seattle
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
Recruiting
- Downtown Emergency Service Center's Overdose Recovery and Care Access Centers, Seattle
About Opioid Overdose
Opioid overdose leads to slowing or stopping of breathing and sometimes death. You can take steps to help prevent an overdose, and respond to one with naloxone.
More about Opioid Overdose on MedlinePlus
Opioid Overdose trials in other cities
- Baltimore, MD18 studies
- New Haven, CT17 studies
- Philadelphia, PA15 studies
- New York City, NY12 studies
- Boston, MA12 studies
- Salt Lake City, UT8 studies
- Pittsburgh, PA7 studies
- Ann Arbor, MI6 studies
- Charleston, SC6 studies
- San Francisco, CA6 studies
- Birmingham, AL6 studies
- Providence, RI6 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.